Affinity Capital Advisors’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
PAM
WT
FWIA
DC
CF
Affinity Capital Advisors's JNJ Position: Q2 2026 in Review
Affinity Capital Advisors reduced its Johnson & Johnson (JNJ) stake by 1.6% in Q2 2026, selling an estimated $8.86K and leaving 2,394 shares worth $621K. The position accounts for 0.08% of the portfolio, ranked #100.
Affinity Capital Advisors first reported a position in JNJ in Q4 2019 and has held it in 27 quarters since. The position peaked at $1M in Q4 2021. 897 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Affinity Capital Advisors held 2,394 shares of Johnson & Johnson worth $621K as of Q2 2026.
- Affinity Capital Advisors sold 38 Johnson & Johnson shares in Q2 2026, an estimated $8.86K.
- Johnson & Johnson made up 0.08% of Affinity Capital Advisors's portfolio in Q2 2026, its #100 holding.
- Affinity Capital Advisors first reported a position in Johnson & Johnson in Q4 2019 and has held it in 27 quarters since.
- Affinity Capital Advisors's Johnson & Johnson position peaked at $1M in Q4 2021.
- 897 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Affinity Capital Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.